Special Issue "Antibody Research in the Era of COVID-19"

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".

Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 163

Special Issue Editor

Prof. Dr. Carolina Ramírez-Santana
E-Mail Website
Guest Editor
Centro de Estudio de Enfermedades Autoinmunes (CREA), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá 111221, Colombia
Interests: COVID; antibody

Special Issue Information

Dear Colleagues,

Currently, COVID-19 is continuing to spread around the world, and the duration of antibodies and antibody level remain poorly understood. We hope this Special Issue will improve our understanding of the immune response in humans after SARS-CoV-2 infection.

We are pleased to invite you to share your work and data on vaccines (both COVID-19 and others), with emphasis on immune response, antibody, and autoimmune phenomena.

In this Special Issue, original research articles, reviews, as well as significant case reports are welcome. Research areas may include (but are not limited to) the following:

  • Immune response of COVID-19 vaccination
  • Side effects of vaccination
  • Antibody titers
  • Autoimmune/inflammatory syndrome induced by adjuvants

We look forward to receiving your contributions.

Prof. Dr. Carolina Ramírez-Santana
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • vaccines
  • immunology
  • vaccination
  • antibody

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop